NYSE:NYT
NYSE:NYTMedia

Pentagon Access Lawsuit Over Press Freedom Might Change The Case For Investing In New York Times (NYT)

The New York Times recently filed a lawsuit against the US Department of Defense and Defense Secretary Pete Hegseth, arguing that new Pentagon rules restricting press access and source-based reporting violate journalists’ constitutional rights and chill independent coverage. This legal clash highlights how government-imposed limits on newsgathering could influence not only press freedom, but also the long-term operating environment for subscription-based news businesses like the Times. We’ll...
NYSE:FBK
NYSE:FBKBanks

How Investors May Respond To FB Financial (FBK) Shifting FirstBank To Federal Reserve Oversight

On December 2, 2025, FB Financial’s subsidiary FirstBank became a member of the Federal Reserve System, with the Federal Reserve replacing the FDIC as its primary federal regulator while FDIC deposit insurance remains unchanged. This shift in oversight reshapes FirstBank’s regulatory framework, an important consideration for how investors think about its risk profile, governance and long-term banking operations. We’ll now examine how FirstBank’s move under Federal Reserve supervision could...
NYSE:BBW
NYSE:BBWSpecialty Retail

Is Build-A-Bear’s (BBW) Hello Kitty Expansion Sharpening Its Experiential Retail Edge Or Stretching It?

In early December 2025, Build-A-Bear Workshop and Sanrio announced plans to expand their Build-A-Bear x Hello Kitty and Friends Workshop concept nationwide, adding new locations at American Dream in New Jersey and Mall of America in Minnesota in early 2026, while also updating investors on completed share repurchases and reaffirming 2025 earnings guidance. The decision to roll out this experience to two of the highest-traffic retail destinations in the United States highlights how...
NYSE:FVRR
NYSE:FVRRProfessional Services

Upward Earnings Revisions Could Be A Game Changer For Fiverr International (FVRR)

In recent days, Fiverr International has attracted increased attention after analysts collectively raised their earnings estimates and assigned the company a top-tier rating based on revised profit expectations. This shift in analyst sentiment highlights how rising confidence in Fiverr’s earnings power, rather than new product announcements, is shaping market interest. We’ll now examine how this wave of upward earnings revisions may reshape Fiverr’s investment narrative and expectations...
NasdaqGS:ASND
NasdaqGS:ASNDBiotechs

Did FDA’s TransCon CNP Review Delay Just Shift Ascendis Pharma’s (ASND) Investment Narrative?

In November 2025, Ascendis Pharma A/S disclosed that the FDA deemed its November 5 submission for TransCon CNP (navepegritide) in children with achondroplasia a major amendment, extending the PDUFA target action date by three months to February 28, 2026. This extension introduces additional regulatory review and timing uncertainty for a key pipeline asset that analysts had viewed as an important future growth driver. We’ll now examine how the extended PDUFA review for TransCon CNP reshapes...
NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

How Investors Are Reacting To Catalyst Pharmaceuticals (CPRX) Upgraded 2025 Sales Outlook And Easing Short Interest

In the past week, Catalyst Pharmaceuticals reported stronger-than-expected third-quarter results, with Firdapse and Agamree driving revenue outperformance and prompting the company to lift its full-year 2025 sales guidance across several products. An interesting angle for investors is that this fundamental improvement coincides with a recent reduction in short interest as a share of float, suggesting shifting sentiment among bearish traders. Now, we’ll examine how the upgraded 2025 sales...
NYSE:BDX
NYSE:BDXMedical Equipment

Is Becton Dickinson (BDX) Quietly Reframing Its Moat Around Everyday Hospital Safety Workflows?

Earlier this month, BD (Becton, Dickinson and Company) and ChemoGLO announced a collaboration that links BD’s 10‑minute HD Check point‑of‑care hazardous drug tests with ChemoGLO’s LC‑MS/MS lab analysis, giving healthcare facilities an integrated way to detect and quantify surface contamination and better protect staff. This pairing of rapid screening with detailed follow‑up results aligns with expert recommendations for both qualitative and quantitative monitoring, underscoring BD’s push to...